| Chen, A.; Tomlinson, A.C.A.; Bieder, R.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), KRAS G12C, and CypA. Protein Data Bank: 9bga. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Bieder, R.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), NRAS Q61R, and CypA. Protein Data Bank: 9bg8. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Saldajeno-Concar, M.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), KRAS G12V, and CypA. Protein Data Bank: 9bg6. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Bieder, R.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), KRAS G13D, and CypA. Protein Data Bank: 9bg5. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Chen, A.; Knox, J.E.; Yano, J.K. (2025). Tri-complex of Compound-2, KRAS G12V, and CypA. Protein Data Bank: 9bg4. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Bieder, R.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), NRAS Q61K, and CypA. Protein Data Bank: 9bg3. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Bieder, R.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Compound-10, KRAS G12V, and CypA. Protein Data Bank: 9bg2. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Bieder, R.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), NRAS WT, and CypA. Protein Data Bank: 9bg0. |
CMCF-ID |
PDB Deposition |
Health |
| Cregg, James; Edwards, Anne V.; Chang, Stephanie; Lee, Bianca J.; Knox, John E. et al. (2025). Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c02314. [PDB: 9bg0, 9bg2, 9bg3, 9bg4, 9bg5, 9bg6, 9bg8, 9bga, 9bgb, 9bgc, 9bgd] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Whittington, D.A. (2025). Crystal structure of PRMT5:MEP50 in complex with MTA and oxamide compound 14. Protein Data Bank: 9n3o. |
CMCF-BM |
PDB Deposition |
Health |
| Cottrell, Kevin M.; Briggs, Kimberly J.; Tsai, Alice; Tonini, Matthew R.; Whittington, Douglas A. et al. (2025). Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion. Journal of Medicinal Chemistry 68(5) , 5097-5119. 10.1021/acs.jmedchem.4c03067. [PDB: 9n3o] |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Tran, N.; Holyoak, T. (2025). Crystal Structure of the Gemella haemolysans Immunoglobulin A1 Protease Trypsin-Like Domain. Protein Data Bank: 9ect. |
CMCF-BM |
PDB Deposition |
Health |
| Tran, Norman; Redzic, Jasmina S.; Eisenmesser, Elan Z.; Holyoak, Todd (2025). The structure of the Gemella haemolysans M26 IgA1 protease trypsin-like domain. Acta Crystallographica Section F:Structural Biology Communications 81(4) . 10.1107/s2053230x25001219. [PDB: 9ect] |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Tomlinson, A.C.A.; Knox, J.E.; Yano, J.K. (2025). Tri-complex of Compound-4, KRAS G12C, and CypA. Protein Data Bank: 9bfw. |
CMCF-ID |
PDB Deposition |
Health |